
Dear all, we decided to leave twitter / X You can find us on Bluesky: weersmalab.bsky.social

Gastroenterologist, Translational research, microbiome & integrative omics analyses, host-microbe interactions in the context of IBD and other chronic diseases

Dear all, we decided to leave twitter / X You can find us on Bluesky: weersmalab.bsky.social

Our Consensus statement on #microbiome testing in clinical practice is out in @LancetGastroHep! authors.elsevier.com/a/1kDP5… Here we recommend how to standardise the framework for test release (indications, pre-testing protocols, sequencing & analysis, result reporting). A thread🧵⬇️

#GUTImage from the #RecentAdvancesInClinicalPractice paper by @arnauvich et al on "Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases" via bit.ly/4dyIID3 @WeersmaLab #IBD

Congratulations to Laura Bolte @umcg. Cum Laude distinction for her PhD studying the relation between #diet #microbiome and #immunity in #ibd and response to immune checkpoint inhibition. Work in her PhD thesis has been published in @NatureMedicine @Gut_BMJ and @JAMAOnc

📢 New Study Alert! 📢Happy to share the latest results from the Lifelines NEXT Mother-Infant cohort! (1/8). Here we profile the gut microbiome in 4,577 longitudinal samples from 714 mother-infant pairs, from 12 weeks of pregnancy to 1 year post-birth doi.org/10.21203/rs.3.rs-533…

I am incredibly proud that 2 out of the 5 top abstracts #UEGWeek are from our department @umcg (out of >3500 abstracts). Huge congratulations to @BourgonjeArno and Anne van der Waai for their groundbreaking work and this important recognition! @my_UEG @LifelinesNL @researchumcg

#GUTImage from the #RecentAdvancesInClinicalPractice paper by @arnauvich et al on "Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases" via bit.ly/4dyIID3 @WeersmaLab #IBD

Amazing meeting at the Paris Immuno-Oncology Conference 2024! So much food for thought from top leaders in microbiome and immunology: @EranElinav, @derosa__lisa, @nsegata, @WeersmaLab, and more. Honored to present our latest work published in @NatImmunol with @julienCMarie1.

#GUTImage from the #RecentAdvancesInClinicalPractice paper by @arnauvich et al on "Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases" via bit.ly/4dyIID3 @WeersmaLab #IBD

Join us on October 13 for the presentation of our Top Abstract Prize Awardee, Arno R. Bourgonje: CROHN'S DISEASE AND ULCERATIVE COLITIS EXHIBIT PRE-DIAGNOSTIC ANTIBODY SIGNATURES WITH SHARED AND DIVERGENT CHANGES TOWARDS DISEASE ONSET 🔬 👉 bit.ly/3yIvcOg #UEGWeek

The gut microbiome acetyltransferase genes were involved in the metabolism of 5-ASA in IBD. However, new findings from @WeersmaLab et al. didn't replicate the original findings: gut.bmj.com/content/early/20…

#GUTImage from the paper by @CasSwarte et al on "Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients" via bit.ly/3LcQlTL @jingyuan_fu @HarmsenHermie @WeersmaLab

here's the working link to the paper (open access) tandfonline.com/doi/full/10.…

Exploring the previously reported gut #microbiome acetyltransferase genes involved in metabolism of 5-ASA in #ibd we could not replicate the original findings from @NatureMedicine in our Dutch 1000IBD cohort. More work needed. @GroMicrobiome gut.bmj.com/content/early/20…

In contrast to previous reports we found limited predictive value of the gut #microbiome (and #metabolome) for response to biological therapy in #IBD Still small sample sizes but relatively similar to other studies. @GroMicrobiome @umcgmdl @researchumcg www-tandfonline-com.proxy-ub…

#GUTImage from the paper by Gabriels et al entitled "Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease" via bit.ly/3YIzWP0 @wouternagengast @researchumcg #IBD #Vedolizumab